VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan

Go back to VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
(NASDAQ: VRXA) Delayed: 1.14 +0.01 (0.88%)
Previous Close $1.13    52 Week High $ 
Open $1.15    52 Week Low $ 
Day High $1.25    P/E N/A 
Day Low $1.08    EPS $ 
Volume 241,464